サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1787223

新膣手術の世界市場

Neovaginal Surgery

出版日
ページ情報
英文 185 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.73円
新膣手術の世界市場
出版日: 2025年08月08日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 185 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

新膣手術の世界市場は2030年までに15億米ドルに達する

2024年に12億米ドルと推定される新膣手術の世界市場は、2030年には15億米ドルに達し、分析期間2024-2030年のCAGRは3.9％で成長すると予測されます。本レポートで分析したセグメントの1つである性別適合手術は、CAGR 3.6％を記録し、分析期間終了時には8億3,790万米ドルに達すると予測されます。腟外形成治療手術セグメントの成長率は、分析期間中CAGR 4.5％と推定されます。

米国市場は3億3,300万米ドルと推定、中国はCAGR7.1％で成長予測

米国の新膣手術市場は、2024年に3億3,300万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを7.1%として、2030年までに3億990万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.6%と3.0%と予測されています。欧州では、ドイツがCAGR 2.2%で成長すると予測されています。

世界の新膣手術市場- 主要動向と促進要因のまとめ

なぜ新膣手術は現代医療で重要性を増しているのか？

新膣手術は、再建手術と性別適合手術の高度に専門化された一分野であり、医療の進歩によって膣の再建を必要とする人の選択肢が広がるにつれて、ますます重要性を増しています。この外科手術は、トランスジェンダー女性の性別確認手術、メイヤー・ロキタンスキー・クスター・ハウザー（MRKH）症候群などの先天性疾患、外傷や腫瘍治療後の再建ニーズなど、さまざまな医学的・個人的理由で行われています。手術手技の進化により、陰茎反転膣形成術や腸膣形成術から、組織拡張術や自家皮膚移植を用いた膣形成術といった非外科的な選択肢まで、さまざまなアプローチで治療成績が著しく向上しています。手術材料と術後ケアの進歩により、機能性、審美的な結果、患者の満足度が向上しています。トランスジェンダー・ヘアケアの受容と認知の高まりも、新膣形成術に対する需要の高まりに寄与しており、この医療分野における専門性の高まりにつながっています。意識と医学的専門知識が進化し続ける中、新膣手術は再建的介入を求める人々に人生を変えるソリューションを提供し、身体的・心理的なメリットを提供しています。

新膣手術市場が直面する課題とは？

新膣手術市場は、その重要性が増しているにもかかわらず、アクセシビリティ、治療結果、規制当局の承認に影響するいくつかの課題に直面しています。最も大きな障壁の1つは、膣形成術やその他の再建術を専門とする高度な訓練を受けた外科医の数が限られていることです。手技が複雑なため、広範な外科的専門知識が必要とされ、専門の医療センターでなければ利用できないです。さらに、これらの手術に関連する高額な費用は、多くの患者にとって経済的な課題となっており、特に、ジェンダーを肯定するケアや再建手術が保険適用外の地域では、このような課題が生じています。もう一つの課題は、狭窄、感染症、機能制限などの術後合併症のリスクであり、これらは長期にわたる経過観察とケアを必要とします。さらに、術後のリハビリテーションの標準化されたプロトコールが存在しないため、患者の転帰にばらつきが生じています。倫理的・法的な考慮もまた、市場の成長を制限する一因となっています。というのも、性別適合手術に関する規制当局の受け入れレベルは国によって異なるからです。トランスジェンダーのヘルスケアや再建手術に関連するスティグマ（烙印）は、アクセスをさらに制限し、必要な医療を受けようとしない人もいます。このような課題に対処するには、医療技術革新だけでなく、政策改革、外科医の研修機会の増加、再建手術や性同一性保持手術の社会的受容の拡大が必要です。

技術の進歩はどのように新膣手術を再構築しているのか？

技術の進歩は、新膣手術の精度、安全性、有効性を向上させる上で極めて重要な役割を果たしています。ロボット支援手術の統合は、複雑な手技の精度を高め、回復時間を短縮し、従来の手術手技に伴うリスクを最小限に抑えています。さらに、組織工学と再生医療における進歩は、機能的で生物学的に適合した新膣構造を作り出すための有望な解決策を提供しています。幹細胞治療と生体工学的膣組織の調査により、長期的な手術結果を改善するための新たな可能性が開かれつつあります。もうひとつの革新的な開発は、術前計画や患者固有の手術ガイドに3Dプリンターを利用することで、解剖学的なカスタマイズが可能になり、手術の精度が向上したことです。疼痛管理の強化や拡張テクニックの最適化など、術後ケア戦略の改善により、患者の経験や機能的成功率がさらに向上しています。さらに、遠隔医療やデジタルヘルスプラットフォームの台頭により、新膣手術を受ける患者の術前診察、術後モニタリング、メンタルヘルスサポートへのアクセスが増加しています。このような技術革新は、手術能力を向上させるだけでなく、新膣手術の分野におけるアクセシビリティと患者中心のケアを向上させています。

新膣手術市場の成長の原動力は？

新膣手術市場の成長は、性別適合手術に対する需要の増加、手術技術の進歩、ヘルスケア政策の改善など、いくつかの要因によって牽引されています。トランスジェンダーの医療ニーズが認知され、受け入れられるようになったことで、膣形成術やその他の性別適合手術の需要が急増し、ヘルスケアプロバイダーが提供する手術を拡大するようになりました。さらに、MRKH症候群のような先天性疾患がより広く認識されるようになり、膣再建を必要とする個人に対する医療介入の増加につながっています。さまざまな国で保険適用範囲が拡大し、政府が支援するヘルスケアの取り組みも、こうした手術を経済的に利用しやすくしています。技術の進歩、特にロボット支援手術と生体工学的組織の進歩は、手術成績をさらに向上させ、合併症を減少させ、これらの介入を求めるより多くの患者を引き付けています。専門手術センターと集学的ヘルスケアチームのネットワークが広がることで、全体的なケアの質が向上し、手術の選択肢に対する信頼が高まっています。性の多様性と再建手術に対する社会の考え方が進化を続ける中、新膣手術の需要は増加し、この専門医療分野のさらなる革新と市場拡大を促進すると予想されます。

セグメント

治療タイプ（性別適合手術、膣形成不全治療手術、膣閉鎖症治療手術）

調査対象企業の例

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Chettawut Plastic Surgery Center
  • Conmed Corporation
  • Gonzalez-Fontana
  • Hologic, Inc.
  • Icahn School of Medicine at Mount Sinai
  • Intuitive Surgical, Inc.
  • Karl Storz SE & Co. KG
  • KESSEL Medintim GmbH
  • Medtronic plc
  • Mylan N.V.
  • Olympus Corporation
  • Owen Mumford Ltd.
  • Phuket Plastic Surgery Institute（PPSI）
  • Smith & Nephew plc
  • Stryker Corporation
  • Thermo Fisher Scientific Inc.
  • Vuvatech

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールで市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP32317

Global Neovaginal Surgery Market to Reach US$1.5 Billion by 2030

The global market for Neovaginal Surgery estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 3.9% over the analysis period 2024-2030. Sex Reassignment Surgery, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$837.9 Million by the end of the analysis period. Growth in the Vaginal Agenesis Treatment Surgery segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$333.0 Million While China is Forecast to Grow at 7.1% CAGR

The Neovaginal Surgery market in the U.S. is estimated at US$333.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$309.9 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global Neovaginal Surgery Market - Key Trends & Drivers Summarized

Why Is Neovaginal Surgery Gaining Significance in Modern Medicine?

Neovaginal surgery, a highly specialized branch of reconstructive and gender-affirming surgery, is becoming increasingly important as medical advancements expand options for individuals requiring vaginal reconstruction. This surgical procedure is performed for various medical and personal reasons, including gender-affirming procedures for transgender women, congenital conditions such as Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome, and reconstructive needs following trauma or oncological treatments. The evolution of surgical techniques has significantly improved outcomes, with approaches ranging from penile inversion vaginoplasty and intestinal vaginoplasty to non-surgical options such as tissue expansion and vaginoplasty using autologous skin grafts. Advancements in surgical materials and postoperative care have enhanced functionality, aesthetic outcomes, and patient satisfaction. The growing acceptance and recognition of transgender healthcare have also contributed to the rising demand for neovaginal procedures, leading to increased specialization in this medical field. As awareness and medical expertise continue to evolve, neovaginal surgery is providing life-changing solutions for individuals seeking reconstructive interventions, offering both physical and psychological benefits.

What Are the Challenges Facing the Neovaginal Surgery Market?

Despite its growing importance, the neovaginal surgery market faces several challenges that impact accessibility, procedural outcomes, and regulatory approvals. One of the most significant barriers is the limited availability of highly trained surgeons specializing in vaginoplasty and other reconstructive techniques. The complexity of the procedure requires extensive surgical expertise, making it accessible only in specialized medical centers. Additionally, the high cost associated with these surgeries poses financial challenges for many patients, particularly in regions where gender-affirming care or reconstructive surgeries are not covered by insurance. Another challenge is the risk of postoperative complications, including stenosis, infections, and functional limitations, which require long-term follow-up and care. Furthermore, there is a persistent lack of standardized protocols for post-surgical rehabilitation, leading to variability in patient outcomes. Ethical and legal considerations also play a role in limiting market growth, as different countries have varying levels of regulatory acceptance regarding gender-affirming surgeries. The stigma associated with transgender healthcare and reconstructive procedures further restricts access and discourages some individuals from seeking necessary medical care. Addressing these challenges requires not only medical innovation but also policy reforms, increased training opportunities for surgeons, and broader societal acceptance of reconstructive and gender-affirming procedures.

How Are Technological Advancements Reshaping Neovaginal Surgery?

Technological advancements are playing a pivotal role in improving the precision, safety, and effectiveness of neovaginal surgery. The integration of robotic-assisted surgery is enhancing the accuracy of complex procedures, reducing recovery times, and minimizing risks associated with traditional surgical techniques. Additionally, advancements in tissue engineering and regenerative medicine are offering promising solutions for creating functional and biologically compatible neovaginal structures. Research into stem cell therapies and bioengineered vaginal tissues has opened new possibilities for improving long-term surgical outcomes. Another transformative development is the use of 3D printing for pre-surgical planning and patient-specific surgical guides, allowing for better anatomical customization and improved surgical accuracy. Improved postoperative care strategies, including enhanced pain management and optimized dilation techniques, are further enhancing patient experience and functional success rates. Moreover, the rise of telemedicine and digital health platforms is increasing access to preoperative consultations, postoperative monitoring, and mental health support for patients undergoing neovaginal procedures. These technological innovations are not only advancing surgical capabilities but also improving accessibility and patient-centered care in the field of neovaginal surgery.

What Is Driving the Growth of the Neovaginal Surgery Market?

The growth in the neovaginal surgery market is driven by several factors, including increasing demand for gender-affirming procedures, advancements in surgical techniques, and improved healthcare policies. The rising visibility and acceptance of transgender healthcare needs have led to a surge in demand for vaginoplasty and other gender-affirming surgeries, prompting healthcare providers to expand their offerings. Additionally, congenital conditions such as MRKH syndrome are becoming more widely recognized, leading to increased medical interventions for individuals requiring vaginal reconstruction. The expansion of insurance coverage and government-backed healthcare initiatives in various countries is also making these procedures more financially accessible. Technological advancements, particularly in robotic-assisted surgery and bioengineered tissues, are further enhancing surgical outcomes and reducing complications, attracting more patients to seek these interventions. The growing network of specialized surgical centers and multidisciplinary healthcare teams is improving the overall quality of care, fostering greater confidence in surgical options. As societal attitudes toward gender diversity and reconstructive surgery continue to evolve, the demand for neovaginal procedures is expected to increase, driving further innovation and market expansion in this specialized field of medicine.

SCOPE OF STUDY:

The report analyzes the Neovaginal Surgery market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery, Vaginal Atresia Treatment Surgery)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Chettawut Plastic Surgery Center
  • Conmed Corporation
  • Gonzalez-Fontana
  • Hologic, Inc.
  • Icahn School of Medicine at Mount Sinai
  • Intuitive Surgical, Inc.
  • Karl Storz SE & Co. KG
  • KESSEL Medintim GmbH
  • Medtronic plc
  • Mylan N.V.
  • Olympus Corporation
  • Owen Mumford Ltd.
  • Phuket Plastic Surgery Institute (PPSI)
  • Smith & Nephew plc
  • Stryker Corporation
  • Thermo Fisher Scientific Inc.
  • Vuvatech

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Neovaginal Surgery - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Gender-Affirming Care Policies Across Healthcare Systems Strengthens Business Case for Neovaginal Surgery
    • Growing Awareness and Acceptance of Transgender Healthcare Expands Addressable Market Opportunity
    • Advances in Surgical Techniques and Tissue Engineering Drive Adoption of Neovaginal Surgery Procedures
    • Increasing Insurance Coverage for Gender Reassignment Surgeries Propels Market Growth
    • Expansion of Transgender-Friendly Healthcare Facilities Accelerates Demand for Specialized Surgical Services
    • Surge in Medical Tourism for Gender-Affirming Procedures Throws the Spotlight on High-Quality Surgical Offerings
    • Development of Minimally Invasive Neovaginal Construction Methods Spurs Growth in Patient Preference
    • Emergence of Robotic-Assisted Surgery Enhances Precision and Drives Premium Pricing Potential
    • Strong Advocacy and Support from LGBTQ+ Organizations Strengthens Policy Push and Market Access
    • Integration of Regenerative Medicine Techniques Expands Innovation Frontier and Market Attractiveness
    • Rising Number of Transgender Individuals Seeking Transition Surgeries Generates Sustained Demand
    • Inclusion of Neovaginal Surgery in National Healthcare Guidelines Drives Institutional Adoption
    • Increasing Collaboration Between Medical Institutions and Transgender Health Experts Bolsters Clinical Standards
    • Regulatory Support for Gender-Affirming Care Accelerates Hospital and Clinic Participation
    • Social Media and Influencer-Led Education Campaigns Spur Awareness and Demand Among Younger Demographics
    • Improved Post-Operative Outcomes and Patient Satisfaction Rates Propel Long-Term Market Confidence
    • Training and Certification Programs for Surgeons Drive Growth of Skilled Workforce and Procedure Uptake
    • Expanding Availability of Customizable Surgical Techniques Enhances Patient-Centric Approaches and Market Differentiation
    • Advances in Preoperative Imaging and Simulation Tools Strengthen Case for Personalized Surgical Planning
    • Ethical and Legal Debates Around Access to Gender-Affirming Care Create Regulatory Complexity and Market Challenges
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neovaginal Surgery Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neovaginal Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neovaginal Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Neovaginal Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Sex Reassignment Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Sex Reassignment Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Vaginal Agenesis Treatment Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Vaginal Agenesis Treatment Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Vaginal Agenesis Treatment Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Vaginal Atresia Treatment Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Vaginal Atresia Treatment Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Vaginal Atresia Treatment Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • JAPAN
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • CHINA
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • EUROPE
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Neovaginal Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Neovaginal Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Neovaginal Surgery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • FRANCE
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • GERMANY
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Spain 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Russia 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Neovaginal Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Neovaginal Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Neovaginal Surgery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Australia 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • INDIA
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: India 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: South Korea 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Neovaginal Surgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Neovaginal Surgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Neovaginal Surgery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Argentina 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Brazil 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Mexico 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Latin America 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Neovaginal Surgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Neovaginal Surgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Middle East 15-Year Perspective for Neovaginal Surgery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Iran 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Israel 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Saudi Arabia 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UAE 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Middle East 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • AFRICA
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Africa 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030

IV. COMPETITION